Inspira Technologies Oxy B.H.N. Ltd. (IINN): Enterprise Value to EBITDA Ratio
The price trajectory for Inspira Technologies Oxy (IINN) shown below is accompanied by the 0.00 indicator. Inspira Technologies Oxy develops energy-efficient blood oxygenation systems that support the implementation of green initiatives in healthcare. The business is protected by exclusive patents and strict FDA oversight, creating high barriers to entry for competitors. The current model relies on the development of a single flagship product, which entails regulatory complexities and a lack of revenue typical for startups.
Comprehensive metric breakdowns and analytics for Inspira Technologies Oxy B.H.N. Ltd. (IINN)
- stock price and consensus target price:
- stock exchange capitalization data:
- business book valuation details:
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio Inspira Technologies Oxy|IINN - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Inspira Technologies Oxy|IINN - Company Total Debt|Debts to Book Capitalization Inspira Technologies|IINN - Long-Term Debt|Company Short-Term Debts Inspira Technologies|Quick Ratio inspira-technologies.com
- financial results and valuation multiples details:
IINN - Net Financial Result|Projected Future Earnings Inspira Technologies Oxy|IINN - Price to Earnings Ratio|Forward P/E Multiple Inspira Technologies Oxy B.H.N. Ltd.|IINN - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Inspira Technologies Oxy B.H.N. Ltd.|IINN - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Inspira Technologies|IINN - Earnings per share for the trailing year|Quarterly EPS earnings growth inspira-technologies.com|IINN - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Inspira Technologies Oxy
- sales volume and revenue indicators:
Analysis of all company metrics:Inspira Technologies Oxy B.H.N. Ltd IINN
Investors assess operational strength via the enterprise value to EBITDA ratio, which isolates the fundamental trend from the impact of debt leverage. The implementation of robotics in the assembly of Inspira Technologies Oxy life support systems reduces costs, and an analysis of the EV/EBITDA metric for this capital-intensive business confirms the efficiency of these investments, determining the company's resilience to market shocks.
Competitor analysis
Dexcom CGM - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio PEN (Penumbra, Inc.)|NOVT: Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio Haemonetics HAE|INSP: EV/EBITDA Multiple|PRCT - Total Company Value to Operating Income Before Depreciation Ratio|CNMD (conmed.com) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Pulse Biosciences (PLSE)|Enterprise Value to EBITDA Ratio INMD (InMode)|Enterprise Value to EBITDA Ratio Picard Medical PMI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Surmodics Inc. SRDX|SENS - Enterprise Value to EBITDA Ratio|NeuroPace Inc - EV/EBITDA Multiple|Company Value to EBITDA tactilemedical.com|SNWV: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Outset Medical|ELMD (Electromed) - EV/EBITDA Multiple|LENSAR, Inc (LNSR) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple RCEL|Enterprise Value to EBITDA Ratio Profound Medical PROF|EV/EBITDA Multiple BDMD (Baird Medical Investment Holdings)|EV/EBITDA Multiple EDAP TMS S.A. EDAP|APYX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ICCM: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|LUNG (Pulmonx Corp.) - Enterprise Value to EBITDA Ratio|TELA Bio Inc. - Business Value to Operating Income Before Depreciation|CTSO (CytoSorbents Corp) - EV/EBITDA Multiple|Company Value to EBITDA Sensus Healthcare Inc SRTS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Zynex Medical (ZYXI)|electroCore Medical (ECOR) - Enterprise Value to EBITDA Multiple|Vicarious Surgical Inc - Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio seastarmedical.com (ICU)|IRIDEX Corp - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Intelligent Bio Solutions Inc. INBS|Beyond Air (XAIR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio PFSA (Profusa, Inc)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization strataskinsciences.com|Enterprise Value to EBITDA Ratio GlucoTrack, Inc. (GCTK)|EV/EBITDA Multiple NAOV|VERO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nuwellis, Inc. NUWE|AEMD: Enterprise Value to Operating Income Before Depreciation|ASXC: Enterprise Value to EBITDA Ratio|Avinger, Inc. - Enterprise Value to Operating Income Before Depreciation Ratio|BSGM: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Cutera, Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization knowlabs.co|Enterprise Value to Operating Income Before Depreciation NARI (Inari)|Enterprise Value to EBITDA Ratio NVRO (Nevro Corp.)|Total Company Value to Operating Income Before Depreciation Ratio ReShape Lifesciences Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization silkroadmed.com SILK
